Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified APRN is developing a prescribing workflow for an
outpatient primary care clinic. Which action best demonstrates the
APRN's responsibility for safe, evidence-based prescribing?
A. Prescribe medications primarily according to patient preference to
improve adherence.
B. Base prescribing decisions on a comprehensive assessment, current
evidence, patient-specific factors, and appropriate follow-up
monitoring.
C. Delegate medication selection to the collaborating pharmacist
whenever possible.
D. Select medications primarily based on insurance formulary status
regardless of clinical appropriateness.
Correct Answer: B
Rationale:
Safe prescribing begins with a comprehensive patient assessment,
accurate diagnosis, consideration of comorbidities, allergies, organ
function, concurrent medications, patient preferences, cost, and
evidence-based guidelines. Appropriate follow-up and monitoring are
essential to evaluate efficacy and detect adverse effects. Patient
preference and formulary considerations are important but should not
,supersede clinical appropriateness. Pharmacists provide valuable
collaboration but prescribing responsibility remains with the APRN.
Question 2
A family nurse practitioner evaluates a 72-year-old patient with
hypertension, chronic kidney disease, and osteoarthritis who takes six
prescription medications and several over-the-counter supplements.
Before initiating a new medication, which action is the highest priority?
A. Prescribe the newest medication in the drug class because it is likely
more effective.
B. Review the complete medication list, including nonprescription
products and supplements, for potential interactions and duplication.
C. Reduce all current medication doses by 50%.
D. Begin the medication immediately and evaluate interactions during
the follow-up visit.
Correct Answer: B
Rationale:
Medication reconciliation is a critical component of safe prescribing,
particularly in older adults with polypharmacy. Reviewing prescription
medications, OTC products, herbal supplements, allergies, and previous
adverse reactions helps identify interactions, therapeutic duplication,
contraindications, and opportunities for deprescribing. Automatic dose
reductions or delaying interaction assessment may increase patient
risk.
Question 3
, An APRN is considering pharmacologic treatment for a patient with
newly diagnosed type 2 diabetes. Which patient characteristic is MOST
important when individualizing medication selection?
A. The patient's favorite pharmacy
B. The patient's blood type
C. Renal function, comorbid conditions, and risk for adverse effects
D. The patient's preferred tablet color
Correct Answer: C
Rationale:
Evidence-based prescribing requires individualized therapy based on
kidney and liver function, cardiovascular disease, heart failure, obesity,
hypoglycemia risk, concomitant medications, cost, and patient
preferences. Pharmacy choice and tablet appearance do not determine
the most appropriate medication.
Question 4
An APRN writes a prescription for an antimicrobial agent. Which
additional intervention most effectively promotes antimicrobial
stewardship?
A. Prescribe the broadest-spectrum agent available.
B. Encourage the patient to save leftover medication for future
infections.
C. Confirm the clinical indication and prescribe the narrowest effective
therapy for the appropriate duration.
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified APRN is developing a prescribing workflow for an
outpatient primary care clinic. Which action best demonstrates the
APRN's responsibility for safe, evidence-based prescribing?
A. Prescribe medications primarily according to patient preference to
improve adherence.
B. Base prescribing decisions on a comprehensive assessment, current
evidence, patient-specific factors, and appropriate follow-up
monitoring.
C. Delegate medication selection to the collaborating pharmacist
whenever possible.
D. Select medications primarily based on insurance formulary status
regardless of clinical appropriateness.
Correct Answer: B
Rationale:
Safe prescribing begins with a comprehensive patient assessment,
accurate diagnosis, consideration of comorbidities, allergies, organ
function, concurrent medications, patient preferences, cost, and
evidence-based guidelines. Appropriate follow-up and monitoring are
essential to evaluate efficacy and detect adverse effects. Patient
preference and formulary considerations are important but should not
,supersede clinical appropriateness. Pharmacists provide valuable
collaboration but prescribing responsibility remains with the APRN.
Question 2
A family nurse practitioner evaluates a 72-year-old patient with
hypertension, chronic kidney disease, and osteoarthritis who takes six
prescription medications and several over-the-counter supplements.
Before initiating a new medication, which action is the highest priority?
A. Prescribe the newest medication in the drug class because it is likely
more effective.
B. Review the complete medication list, including nonprescription
products and supplements, for potential interactions and duplication.
C. Reduce all current medication doses by 50%.
D. Begin the medication immediately and evaluate interactions during
the follow-up visit.
Correct Answer: B
Rationale:
Medication reconciliation is a critical component of safe prescribing,
particularly in older adults with polypharmacy. Reviewing prescription
medications, OTC products, herbal supplements, allergies, and previous
adverse reactions helps identify interactions, therapeutic duplication,
contraindications, and opportunities for deprescribing. Automatic dose
reductions or delaying interaction assessment may increase patient
risk.
Question 3
, An APRN is considering pharmacologic treatment for a patient with
newly diagnosed type 2 diabetes. Which patient characteristic is MOST
important when individualizing medication selection?
A. The patient's favorite pharmacy
B. The patient's blood type
C. Renal function, comorbid conditions, and risk for adverse effects
D. The patient's preferred tablet color
Correct Answer: C
Rationale:
Evidence-based prescribing requires individualized therapy based on
kidney and liver function, cardiovascular disease, heart failure, obesity,
hypoglycemia risk, concomitant medications, cost, and patient
preferences. Pharmacy choice and tablet appearance do not determine
the most appropriate medication.
Question 4
An APRN writes a prescription for an antimicrobial agent. Which
additional intervention most effectively promotes antimicrobial
stewardship?
A. Prescribe the broadest-spectrum agent available.
B. Encourage the patient to save leftover medication for future
infections.
C. Confirm the clinical indication and prescribe the narrowest effective
therapy for the appropriate duration.
